Digital technologies for cognitive assessment are far from new, but they may also be far from ideal, especially in terms of validation and ease of use. As a medical device company, Philips has a long history of developing clinical offerings that are steeped in clinical insights. We research, validate, and utilize clinical studies so we can offer patients, neurologists and neuropsychologists a tool that’s rapid, reliable and readily accessible – Philips IntelliSpace Cognition.
According to neurologists, the two most important factors they consider when choosing a digital cognition assessment tool are whether the tool is well validated and whether it is easy to use. Specifically, survey results showed that these factors were ranked as “very important” by 73% and 72% of respondents, respectively.1